Congress trades

HealthEquity, Inc. (HQY)

NASDAQ · Healthcare · 23 congress trades · last filed 2 months ago

20
Congress disclosures shown
36d
Median delay on the congress disclosures
of the 45 day limit
12 buys·8 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades HQY.

Free on iOS and Android.

About HealthEquity, Inc.

from the company's filings and listing, as of Oct 28, 2026
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Chief executive
Scott R. Cutler
Employees
2,814
Listed since
-
Market value
$8.3B
Price to earnings (12 mo)
36.0
Net income per share, as reported (12 mo)
$2.84
Dividend yield
-

www.healthequity.com

Earnings

6 reported quarters · next on Dec 2, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2027reported Aug 27, 2026$1.24$1.19$350.7M$349.2MEPS beatRevenue in line
Q1 FY2027reported May 28, 2026$1.24$1.11$354.6M$352.0MEPS beatRevenue in line
Q4 FY2026reported Mar 17, 2026$0.95$0.89$334.6M$332.3MEPS beatRevenue in line
Q3 FY2026reported Dec 3, 2025$1.01$0.91$322.2M$320.6MEPS beatRevenue in line
Q2 FY2026reported Sep 2, 2025$1.08$0.91$325.8M$320.7MEPS beatRevenue beat
Q1 FY2026reported Jun 3, 2025$0.97$0.81$330.8M$322.3MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2026 · proxy filed May 13, 2026
ExecutiveSalaryStock awardsOtherTotal
Scott CutlerPresident and Chief Executive Officer$775K$12.0M$769K$13.6M
James LucaniaExecutive Vice President and Chief Financial Officer$575K$4.1M$487K$5.2M
Michael FioreExecutive Vice President and Chief Commercial Officer$550K$3.2M$413K$4.2M
Delano LaddExecutive Vice President and General Counsel$400K$2.9M$310K$3.6M
Stephen Neeleman, M.D.Founder and Vice Chairman$492K$2.6M$369K$3.5M

The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$1.0B11,277,914+7.1%13.53%
Wasatch Advisors LP$719.0M7,960,735+10.5%9.55%
Morgan Stanley$410.7M4,547,219+82.9%5.45%
Vanguard Portfolio Management LLC$366.5M4,057,643-2.5%4.87%
Vanguard Capital Management LLC$328.8M3,640,776-4.8%4.37%
State Street Corp$292.7M3,241,046+4.6%3.89%
Geode Capital Management, LLC$214.5M2,374,467+5.1%2.85%
AQR Capital Management LLCCliff Asness$176.1M1,999,209-4.4%2.40%
Dimensional Fund Advisors LP$168.8M1,869,036+14.9%2.24%
William Blair Investment Management, LLC$160.2M1,773,227+6.8%2.13%
FMR LLC$138.9M1,538,387+35.5%1.85%
Brown Advisory Inc$124.0M1,372,624-2.8%1.65%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next HQY filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in HQY

20 disclosures of 23 on record · median 36d of the 45 allowed

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.Filed lateStockPurchase$1,001 - $15,000+9.9% since the tradeEstimated entry price $94.40, close on Fri Jul 10Current price $103.75, close on Mon Oct 26Jul 10, 2026Sep 4, 202656d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+14.9% since the tradeEstimated entry price $90.32, close on Tue Jun 30Current price $103.75, close on Mon Oct 26Jun 30, 2026Jul 2, 20262d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+17.9% since the tradeEstimated entry price $87.99, close on Fri May 29Current price $103.75, close on Mon Oct 26May 29, 2026Jun 8, 202610d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000-0.8% since the tradeEstimated entry price $104.56, close on Wed Jun 11, 2025Current price $103.75, close on Mon Oct 26Jun 11, 2025Aug 13, 202563d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+3.7% since the saleEstimated exit price $100.01, close on Tue Jun 17, 2025Current price $103.75, close on Mon Oct 26Jun 17, 2025Aug 13, 202557d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+2.6% since the saleEstimated exit price $101.08, close on Mon Jun 16, 2025Current price $103.75, close on Mon Oct 26Jun 16, 2025Jul 10, 202524d
Robert BresnahanJointStockSale$1,001 - $15,000+1.9% since the saleEstimated exit price $101.82, close on Mon Jan 13, 2025Current price $103.75, close on Mon Oct 26Jan 13, 2025Feb 13, 202531d
Josh GottheimerJointStockSale$1,001 - $15,000+6.7% since the saleEstimated exit price $97.20, close on Thu Nov 7, 2024Current price $103.75, close on Mon Oct 26Nov 7, 2024Dec 5, 202428d
Josh GottheimerJointStockSale$1,001 - $15,000n/aJun 21, 2024Jul 9, 202418d
Blake D. MooreStockSale$1,001 - $15,000n/aJan 19, 2024Jan 24, 20245d
Daniel S. GoldmanStockSale$15,001 - $50,000n/aApr 10, 2023May 19, 202339d
Josh GottheimerJointStockPurchase$1,001 - $15,000n/aJan 10, 2022Feb 18, 202239d
Josh GottheimerJointStockSale$1,001 - $15,000n/aDec 9, 2021Jan 10, 202232d
Blake D. MooreStockPurchase$1,001 - $15,000n/aMar 26, 2021Jul 17, 2021113d
Blake D. MooreStockPurchase$1,001 - $15,000n/aApr 30, 2021Jul 17, 202178d
Blake D. MooreStockPurchase$1,001 - $15,000n/aMay 11, 2021Jul 17, 202167d
Blake D. MooreStockPurchase$1,001 - $15,000n/aMay 12, 2021Jul 17, 202166d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000n/aJul 17, 2020Aug 19, 202033d
Josh GottheimerJointStockPurchase$1,001 - $15,000n/aJul 9, 2020Aug 10, 202032d
Josh GottheimerJointStockPurchase$1,001 - $15,000n/aApr 3, 2020May 13, 202040d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in HQY, filterable by party, chamber, type and account.

Members of Congress reporting a position

2 members · estimate, as of Oct 27, 2026

2 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$50,001 - $100,0000.2%
Josh GottheimerDemocrat · House$1,001 - $15,000<0.1%

Estimate, as of Oct 27, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Which members of Congress have traded HQY?

Gilbert Ray Cisneros, Jr., Lisa C. McClain, Robert Bresnahan, Josh Gottheimer, Blake D. Moore and Daniel S. Goldman disclosed HQY transactions in the filings shown here.

Which members of Congress hold HQY?

2 members of Congress report a position in HQY in the estimate we hold as of Oct 27, 2026. The estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are HQY trades disclosed?

Congressional disclosures took a median of 36 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 28, 2026.

Related companies

traded by the same members

See every company we track